C2 - complement C2 Gene

Homo sapiens

Also known as CO2; ARMD14

Gene ID: 717 | Gene type: protein coding

About C2

Cytogenetic location: 6p21.33 Genomic coordinates (GRCh38): 6:31,897,783-31,945,672 (from NCBI)

This gene has 24 transcripts (splice variants), 1 gene allele, 85 orthologues, 39 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 95.8), lung (RPKM 36.7) and 11 other tissues.

Summary

Component C2 is a serum glycoprotein that functions as part of the classical pathway of the Complement System. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]

C2 Products(6)

mRNA	Protein	Name
NM_000063.6	NP_000054.2	complement C2 isoform 1 preproprotein
NM_001145903.3	NP_001139375.1	complement C2 isoform 2 precursor
NM_001178063.3	NP_001171534.1	complement C2 isoform 3
NM_001282457.2	NP_001269386.1	complement C2 isoform 4
NM_001282458.2	NP_001269387.1	complement C2 isoform 5
NM_001282459.2	NP_001269388.1	complement C2 isoform 6 precursor

Gene Ontology

Molecular Function
Biological Process

Molecular Function GO Annotation	Evidence	Reference	Source
enables protein binding	IPI IPI: Inferred from physical interaction	25910212	GOA

Biological Process GO Annotation	Evidence	Reference	Source
involved in complement activation	IMP IMP: Inferred from mutant phenotype	19302245	GOA
involved in positive regulation of apoptotic cell clearance	IMP IMP: Inferred from mutant phenotype	19302245	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C2 Protein Structure

Sushi

VWA

Trypsin

0
200
400
600
752 a.a.

Protein Preferred Names

Protein Names

complement C2

C3/C5 convertase

Recombinant C2 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P74375	C2/Complement C2 Protein, Human (HEK293, His)	P06681 (A21-L752)	≥95%
HY-P74376	C2/Complement C2 Protein, Human (HEK293, Fc)	P06681 (A21-L752)	≥95%

Related Diseases

Diseases

Alias

Complement Component 2 Deficiency

C2D	C2 Deficiency
Complement 2 Deficiency	Complement Component-2

Macular Degeneration, Age-Related, 14

Age Related Macular Degeneration 14	ARMD14
Macular Degeneration, Age-Related, 14, Reduced Risk Of	Macular Degeneration, Age-Related, Type 14

Immunodeficiency Due To A Classical Component Pathway Complement Deficiency

Immunodeficiency Due To C1, C4, Or C2 Component Complement Deficiency

Immunodeficiency Due To An Early Component Of Complement Deficiency

Retinal Drusen

Eye Disease

Eye Diseases	Abnormality Of The Eye
Toxoplasma Oculopathy

Lupus Erythematosus

Lupus	Lupus Vulgaris
Lupus Erythematosus, Discoid	Lupus Erythematosus, Systemic
Subacute Cutaneous Lupus	Le - [Lupus Erythematosus]

Macular Degeneration, Age-Related, 1

Macular Degeneration	Age-Related Macular Degeneration
Macular Degeneration, Age-Related	Age Related Macular Degeneration
Age Related Macular Degeneration 1	ARMD1
Senile Macular Degeneration	Maculopathy, Age-Related, 1
Macular Degeneration, Age-Related, Reduced Risk Of	Age Related Maculopathy 1
Age Related Maculopathies	Age Related Maculopathy
Senile Macular Retinal Degeneration	Macular Degeneration Of Retina
Age-Related Maculopathy	Amd
Armd	Age-Related Maculopathy, Susceptibility To
Maculopathy Age-Related	Macular Degeneration, Age-Related, 1, Susceptibility To
Maculopathy, Age-Related	Macular Degeneration, Age-Related, Type 1
Macular Degeneration, Age-Related, 2

Systemic Lupus Erythematosus

Lupus Nephritis	SLE
Disseminated Lupus Erythematosus	Systemic Lupus Erythematosus, Susceptibility To
Lupus Erythematosus, Systemic	Lupus Nephritis, Susceptibility To
Libman-Sacks Disease	Systemic Lupus Erythematosus Susceptibility To
Sle - Lupus Erythematosus, Systemic	Le Syndrome
Lupus	Lupus Erythematosus Systemic
Lupus Erythematosus, Systemic, Susceptibility To	Lupus Vulgaris
Lupus Erythematosus, Discoid	Lupus Erythematosus
Systemic Lupus Erythematosus Nos	Sle - [Systemic Lupus Erythematosus]

Degeneration Of Macula And Posterior Pole

Degeneration Of Macula And Posterior Pole Of Retina	Degeneration Of Macula Or Posterior Pole
Macular Degeneration Nos	Degenerative Disorder Of Macula
Drusen Macular Degeneration	Posterior Pole Macular Degeneration Of Eye
Macular Eye Degeneration	Macular Degeneration Of Retina, Unspecified
Pseudohole Degeneration Of Macula Of Retina

Hemolytic Uremic Syndrome, Atypical 1

Atypical Hemolytic-Uremic Syndrome	Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1
Atypical Hemolytic Uremic Syndrome	Hemolytic Uremic Syndrome, Atypical, Susceptibility To
Ahus	AHUS1
Hemolytic-Uremic Syndrome	Ahus 1
Ahus, Susceptibility To, 1	Hemolytic Uremic Syndrome, Atypical
Non-Shiga-Like Toxin-Associated Hus	Non-Stx-Hus
Nonenteropathic Hus	Atypical Hus
Shiga Toxin-Associated Hemolytic Uremic Syndrome	D+ Hus
Ehec-Hus	Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli
Hemolytic Uremic Syndrome With Diarrhea	Stec-Hus
Shiga-Like Toxin-Associated Hus	Stx-Hus
Typical Hus	Typical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies	Atypical Hus With Anti-Factor H Antibodies
Ahus With Anti-Factor H Antibodies	Ahus With Neutralizing Autoantibodies Against Factor H
Hemolytic Uremic Syndrome Atypical 1	Atypical Hemolytic Uremic Syndrome With H Factor Anomaly
D Hus	Hemolytic-Uremic Syndrome Without Diarrhea
Hemolytic-Uremic Syndrome, Atypical, Type 1	Hemolytic Uremic Syndrome, Typical

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0581	Dexrazoxane		99.88%	Yes
HY-B1915	Micronomicin	Inhibitor	95.16%	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99050	Sutimlimab	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Phase
HY-N0379	D-Mannose		≥98.0%	Phase 4
HY-113697	Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD		99.77%	Phase 1

Inhibitory Antibodies (3)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P990091	Riliprubart	Inhibitor	99.90%	Phase 3
HY-P99163	Tilavonemab	Inhibitor	/	Phase 2
HY-P990025	Empasiprubart		97.93%	Phase 2

Pre-clinical Phase

Bioactive Molecules (646)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-N0155	Nobiletin		99.52%	Unkown
HY-113071A	Mevalonic acid lithium salt		99.80%	Unkown
HY-40171	NH2-C2-NH-Boc		99.97%	Unkown
HY-W021401	Amino-PEG3-C2-Azido		99.67%	Unkown
HY-N0376	Liquiritin		99.68%	Unkown
HY-140213	Azido-PEG2-C2-amine		99.85%	Unkown
HY-130109	N3-PEG4-C2-NHS ester		98.94%	Unkown
HY-101180	C2 Ceramide		99.85%	Unkown
HY-42776	NH2-PEG3-C2-NH-Boc		99.34%	Unkown
HY-W008474	Boc-NH-PEG2-C2-NH2		99.01%	Unkown
HY-100594	EUK-134	Inhibitor	98.08%	Unkown
HY-128834	N3-PEG4-C2-NH2		≥98.0%	Unkown
HY-122502	Pyrazofurin	Inhibitor	≥98.0%	Unkown
HY-150795	SY-LB-35		≥98.0%	Unkown
HY-126528	N3-PEG3-C2-NHS ester		99.94%	Unkown
HY-130653	Azido-PEG4-C2-acid		≥98.0%	Unkown
HY-126526	N3-PEG2-C2-NHS ester		≥98.0%	Unkown
HY-140452	Azido-PEG2-C2-acid		≥97.0%	Unkown
HY-130485	Bromo-PEG2-C2-azide		98.10%	Unkown
HY-42149	NH2-PEG2-C2-Boc		≥98.0%	Unkown
HY-W015088	Amino-PEG3-C2-Amine		99.32%	Unkown
HY-137320	diABZI-C2-NH2	Agonist	96.09%	Unkown
HY-N0602	Ginsenoside Rg2	Inhibitor	98.11%	Unkown
HY-135804	NH2-PEG3-C2-Boc		≥97.0%	Unkown
HY-112821	IBS008738	Activator	98.22%	Unkown
HY-130549	Acid-PEG3-C2-Boc		≥97.0%	Unkown
HY-107452	SLF-amido-C2-COOH		99.82%	Unkown
HY-125843	Pomalidomide-PEG1-C2-N3		99.91%	Unkown
HY-W092043	TLR4-IN-C34-C2-COOH	Inhibitor	≥97.0%	Unkown
HY-W022240	NH2-PEG5-C2-NH-Boc		≥95.0%	Unkown
HY-147007	β-catenin-IN-3	Inhibitor	98.03%	Unkown
HY-150644	S07-2010	Inhibitor	99.79%	Unkown
HY-156406	PITCOIN4	Inhibitor	99.97%	Unkown
HY-42151	Mal-amido-PEG2-C2-acid		99.58%	Unkown
HY-130436	Acid-C2-PEG4-C2-NHS ester		≥98.0%	Unkown
HY-140009	Azido-PEG1-C2-acid		≥98.0%	Unkown
HY-D0187S	L-Glutathione reduced-13C2,15N	Inhibitor	≥99.0%	Unkown
HY-126502	Mal-C2-NHS ester		99.30%	Unkown
HY-W017970	Boc-C2-NH2		99.63%	Unkown
HY-124569	NAB-14	Antagonist	/	Unkown
HY-126520	N3-C2-NHS ester		≥98.0%	Unkown
HY-140480	Acid-PEG2-C2-Boc		≥98.0%	Unkown
HY-141364	Bromo-PEG1-C2-Boc		98.58%	Unkown
HY-163084	HJ445A	Inhibitor	98.31%	Unkown
HY-108307	Micronomicin sulfate	Inhibitor	≥98.0%	Unkown
HY-112820	Chlorantraniliprole	Activator	98.06%	Unkown
HY-147025	(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine		99.06%	Unkown
HY-148896	(S,R,S)-AHPC-C2-PEG3-BCN		≥98.0%	Unkown
HY-W040165	Amino-PEG3-C2-acid		99.94%	Unkown
HY-101159	Mal-amido-PEG8-C2-acid		99.04%	Unkown
HY-112452	SU11652		99.06%	Unkown
HY-128846A	Pomalidomide-C2-NH2 hydrochloride		99.46%	Unkown
HY-148346A	STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA	Agonist	98.30%	Unkown
HY-22335	Amino-PEG4-C2-amine		≥98.0%	Unkown
HY-B0351S2	Taurine-13C2,15N	Inducer	98.60%	Unkown
HY-W040168	Amino-PEG2-C2-acid		≥98.0%	Unkown
HY-131880	Thalidomide-O-C2-acid	Inducer	95.04%	Unkown
HY-137531	Pomalidomide-PEG1-C2-COOH		99.76%	Unkown
HY-119678	Fortunellin	Activator	96.51%	Unkown
HY-124648	SMN-C2		98.85%	Unkown
HY-130315	Br-PEG4-C2-Boc		≥98.0%	Unkown
HY-130483	Br-PEG3-C2-Boc		≥97.0%	Unkown
HY-140127	Azide-C2-SS-C2-biotin		98.79%	Unkown
HY-W021448S1	Glycocyamine-15N,13C2		≥97.0%	Unkown
HY-112706	PF-06747711	Antagonist	99.86%	Unkown
HY-129703B	Thalidomide-PEG2-C2-NH2 hydrochloride	Inducer	99.89%	Unkown
HY-112599B	Pomalidomide-PEG4-C2-NH2 hydrochloride		97.01%	Unkown
HY-N0322S5	Cholesterol-13C2	Agonist	99.76%	Unkown
HY-N0543S	Allantoin-13C2,15N4		99.90%	Unkown
HY-N1517	Ganoderic acid C2		99.30%	Unkown
HY-W010098S1	Terephthalic acid-13C2		98.58%	Unkown
HY-W039168	Bromo-PEG3-C2-acid		≥97.0%	Unkown
HY-W580022	Pomalidomide-5'-PEG8-C2-COOH		98.21%	Unkown
HY-128716A	Pomalidomide-PEG3-C2-NH2 TFA		99.0%	Unkown
HY-130683	Lenalidomide-propargyl-C2-NH2 hydrochloride		98.04%	Unkown
HY-128832	Nutlin-C1-amido-PEG4-C2-N3		99.19%	Unkown
HY-115384	Amino-PEG5-C2-acid		≥97.0%	Unkown
HY-135868	Mito-apocynin (C2)	Inhibitor	98.38%	Unkown
HY-139848	WS-898	Inhibitor	98.14%	Unkown
HY-140543	N-DBCO-N-bis(PEG2-C2-acid)		96.65%	Unkown
HY-140585	N-DBCO-N-bis(PEG2-C2-NHS ester)		≥96.0%	Unkown
HY-141386	Bromoacetamido-PEG2-C2-NHS ester		≥95.0%	Unkown
HY-23167	Acid-PEG4-C2-Boc		/	Unkown
HY-B0228S10	(R)-3-Hydroxybutanoic acid-13C2 sodium		≥98.0%	Unkown
HY-N7627	Regaloside C		≥99.0%	Unkown
HY-P5881	PKCα (C2-4) inhibitor peptide	Inhibitor	99.81%	Unkown
HY-Y0262S1	Oxalic acid-13C2		99.45%	Unkown
HY-Y0966S3	Glycine-13C2		99.10%	Unkown
HY-Y0966S6	Glycine-13C2,15N		≥99.0%	Unkown
HY-N0091S3	Hypoxanthine-13C2,15N		≥91.0%	Unkown
HY-13836	ELQ-300	Inhibitor	≥98.0%	Unkown
HY-122710A	Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride	Inducer	≥95.0%	Unkown
HY-136163	(S,R,S)-AHPC-C2-NH2 dihydrochloride		98.63%	Unkown
HY-130108	N3-PEG4-C2-Pfp ester		≥97.0%	Unkown
HY-130414	Mal-amido-PEG4-acid		99.39%	Unkown
HY-133597	4-Chlorocatechol		99.37%	Unkown
HY-134512	Aminooxy-PEG3-C2-thiol		≥95.0%	Unkown
HY-140819	Bromo-PEG1-C2-azide		99.45%	Unkown
HY-B0351S1	Taurine-13C2	Inducer	99.0%	Unkown
HY-129703A	Thalidomide-PEG2-C2-NH2 TFA	Inducer	99.39%	Unkown
HY-107440A	Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride	Inducer	98.29%	Unkown
HY-112608	CHMFL-PI3KD-317	Inhibitor	98.04%	Unkown
HY-122694A	Thalidomide-O-amido-PEG-C2-NH2 hydrochloride	Inducer	98.10%	Unkown
HY-130521	Pomalidomide-amido-PEG3-C2-NH2		99.55%	Unkown
HY-100246	CI-1044	Inhibitor	98.02%	Unkown
HY-115450	ONO-0300302	Antagonist	99.43%	Unkown
HY-126512	Propargyl-C2-NHS ester		≥95.0%	Unkown
HY-126688	Mal-C2-Gly3-EDA-PNU-159682		93.43%	Unkown
HY-126881	Fmoc-PEG2-C2-NHS ester		98.89%	Unkown
HY-130095	NHPI-PEG2-C2-NHS ester		98.23%	Unkown
HY-130101	Ald-Ph-amido-PEG4-C2-NHS ester		98.75%	Unkown
HY-130396	DBCO-PEG4-C2-acid		99.22%	Unkown
HY-130520	Bromoacetamido-PEG4-C2-Boc		≥97.0%	Unkown
HY-130531	NH-bis(C2-PEG2-NH-Boc)		≥98.0%	Unkown
HY-131295	PD0325901-O-C2-dioxolane	Inhibitor	98.76%	Unkown
HY-131866	(S,R,S)-CO-C2-acid		≥98.0%	Unkown
HY-134682	Fmoc-NH-PEG5-C2-NH2		98.06%	Unkown
HY-136162	Thalidomide-4-O-C2-NH2 hydrochloride	Inducer	99.37%	Unkown
HY-13966S2	2-Deoxy-D-glucose-13C		≥98.0%	Unkown
HY-141362	Bromo-PEG2-C2-acid		≥97.0%	Unkown
HY-145245	TLR4-IN-C34-C2-amide-C6-OH	Inhibitor	99.62%	Unkown
HY-148080	Indole-C2-amide-C2-NH2		99.42%	Unkown
HY-162809	XMU-MP-9		98.16%	Unkown
HY-B0389S15	D-Glucose-13C2-4		≥98.0%	Unkown
HY-N6980	Licorice glycoside C2		99.07%	Unkown
HY-133358	Cbz-NH-PEG12-C2-acid		95.66%	Unkown
HY-W017387S1	Sodium α-ketoisocaproic acid-13C2		98.1%	Unkown
HY-W025074	BML-278	Activator	98.49%	Unkown
HY-W128417S	4-(Dimethylamino)phenacyl bromide-13C2,d6		98.14%	Unkown
HY-107440	Thalidomide-O-amido-PEG3-C2-NH2	Inducer	/	Unkown
HY-112600A	Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA	Inducer	99.28%	Unkown
HY-112617A	Thalidomide-O-amido-PEG2-C2-NH2 TFA	Inducer	99.72%	Unkown
HY-128591	DIPQUO	Activator	98.70%	Unkown
HY-130682	Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride		/	Unkown
HY-130853	Thalidomide-NH-PEG2-C2-NH-Boc	Inducer	98.37%	Unkown
HY-112599	Pomalidomide-PEG4-C2-NH2		95.11%	Unkown
HY-103154	SB228357	Antagonist	99.43%	Unkown
HY-103611	Thalidomide-O-amido-PEG3-C2-NH2 TFA	Inducer	99.55%	Unkown
HY-108440	Shz-1		99.88%	Unkown
HY-113071	Mevalonic acid		≥99.0%	Unkown
HY-120773	Fmoc-PEG3-C2-NHS ester		≥95.0%	Unkown
HY-121982	Cyclo(L-Phe-L-Val)	Inhibitor	99.88%	Unkown
HY-126381	Boc-N-PEG5-C2-NHS ester		96.91%	Unkown
HY-126507	Mal-amido-PEG1-C2-NHS ester		99.69%	Unkown
HY-126509	Mal-amido-PEG10-C2-NHS ester		95.23%	Unkown
HY-128716	Pomalidomide-PEG3-C2-NH2		/	Unkown
HY-128716B	Pomalidomide-PEG3-C2-NH2 hydrochloride		/	Unkown
HY-128846	Pomalidomide-C2-NH2		/	Unkown
HY-128848	Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH		95.02%	Unkown
HY-130091	NHPI-PEG4-C2-NHS ester		98.88%	Unkown
HY-130097	Ald-Ph-amido-PEG4-C2-acid		99.09%	Unkown
HY-130104	Ald-Ph-amido-PEG2-C2-NHS ester		98.51%	Unkown
HY-130470	Chloroacetamido-PEG4-C2-Boc		/	Unkown
HY-133070	Tos-PEG5-C2-Boc		/	Unkown
HY-135085	Thiol-C2-PEG2-OH		≥97.0%	Unkown
HY-136395	Cartap	Inducer	/	Unkown
HY-13677S1	6-Mercaptopurine-13C2,15N		≥96.0%	Unkown
HY-138446	Amino-PEG4-C2-SH hydrochloride		≥95.0%	Unkown
HY-138451	Amino-PEG7-C2-SH hydrochloride		≥98.0%	Unkown
HY-140779	Azido-PEG6-C2-Boc		99.77%	Unkown
HY-141941S	Triazole Lactic Acid-13C2, 15N3		/	Unkown
HY-148136	sEH inhibitor-7	Inhibitor	99.71%	Unkown
HY-148346	STING agonist-20-Ala-amide-PEG2-C2-NH2	Agonist	/	Unkown
HY-148484	Pomalidomide-5'-PEG5-C2-COOH		98.80%	Unkown
HY-160897	Methoxy-PEG-C3-amide-C2-Mal		99.69%	Unkown
HY-164367	Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT		/	Unkown
HY-16973S	Fluralaner-13C2,15N,d3	Inhibitor	98.35%	Unkown
HY-66005S4	Acetaminophen-13C2,15N		/	Unkown
HY-A0132S10	N-Acetyl-D-glucosamine-13C2,15N		/	Unkown
HY-B0166S3	L-Ascorbic acid-13C-2		≥95.0%	Unkown
HY-B0318S	Metronidazole-13C2,15N2		99.30%	Unkown
HY-I0960S	Uracil-13C2,15N2		≥97.0%	Unkown
HY-N0229S15	L-Alanine-13C2,15N		≥99.0%	Unkown
HY-N0229S9	L-Alanine-13C2		≥98.0%	Unkown
HY-N0437S3	Progesterone-13C2	Agonist	99.7%	Unkown
HY-N0455AS5	L-Arginine-1,2-13C2 hydrochloride	Activator	98.9%	Unkown
HY-N0666S6	L-Aspartic acid-1,4-13C2		≥99.0%	Unkown
HY-N0830S10	Palmitic acid-13C2	Activator	99.54%	Unkown
HY-P2741	Maltose phosphorylase		/	Unkown
HY-W013636S3	2-Ketoglutaric acid-13C		≥97.0%	Unkown
HY-W040795	N2-Acetylguanine		99.69%	Unkown
HY-W127841	Citric acid-2,4-13C2		98.00%	Unkown
HY-Y0674S	Dicyandiamide-13C2,15N2		99.90%	Unkown
HY-103708	Nezukone		98.81%	Unkown
HY-159193S	DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA		97.61%	Unkown
HY-47373	Folate-PEG3-C2-acid		97.56%	Unkown
HY-112600	Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2	Inducer	/	Unkown
HY-112617	Thalidomide-O-amido-PEG2-C2-NH2	Inducer	/	Unkown
HY-112617B	Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride	Inducer	/	Unkown
HY-122694	Thalidomide-O-amido-PEG-C2-NH2	Inducer	/	Unkown
HY-128353	ROR agonist-1	Antagonist	/	Unkown
HY-129703	Thalidomide-PEG2-C2-NH2	Inducer	/	Unkown
HY-131308	Thalidomide-NH-C2-PEG3-OH	Inducer	/	Unkown
HY-136160	Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride	Inducer	/	Unkown
HY-141662	2',3'-cGAMP-C2-PPA	Agonist	/	Unkown
HY-122710	Thalidomide-O-amido-PEG4-C2-NH2		/	Unkown
HY-125883	Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc		/	Unkown
HY-100441S1	Treprostinil-13C2,d1	Inhibitor	/	Unkown
HY-101047S1	D-erythro-Sphingosine-13C2,d2		/	Unkown
HY-101108S1	Tazarotenic acid-13C2,d2		/	Unkown
HY-103155	SB-221284	Antagonist	/	Unkown
HY-108379	Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid		/	Unkown
HY-108826	Iduronate sulfatase		/	Unkown
HY-109506S9	DPPC-13C2		/	Unkown
HY-110189S	Pregnenolone monosulfate sodium-13C2,d2		/	Unkown
HY-111095S3A	D-(-)-Lactic acid-13C-2 sodium		/	Unkown
HY-111555	AmPEG6C2-Aur0131	Inhibitor	/	Unkown
HY-113071C	(S)-Mevalonic acid		/	Unkown
HY-113263S1	17α-Hydroxypregnenolone-13C2,d2		/	Unkown
HY-113295S	Salicyluric acid-13C2,15N		/	Unkown
HY-113365S2	Cholestenone-13C2		/	Unkown
HY-115945	Complex III-IN-1	Inhibitor	/	Unkown
HY-116877	C2 Ceramide (d14:1/2:0)		/	Unkown
HY-117356A	MRS2693 ammonium		/	Unkown
HY-118574	UBP141	Antagonist	/	Unkown
HY-121507	Hydroxy-PEG2-C2-sulfonic acid		/	Unkown
HY-123439	FTY720-C2		/	Unkown
HY-125172	PolyQ aggregation inhibitor C2-8		/	Unkown
HY-125887	Boc-NH-PEG2-C2-amido-C4-acid		/	Unkown
HY-126026	NF-κB-IN-17	Inhibitor	/	Unkown
HY-126313	BnOH-NH-bis-(C2-S)-propane-O-isoprene ester		/	Unkown
HY-126508	Mal-amido-PEG5-C2-NHS ester		/	Unkown
HY-12650S	Mirogabalin-13C2,d1 (Mixture of Diastereomers)		/	Unkown
HY-126510	MC-PEG2-C2-NHS ester		/	Unkown
HY-126514	Propargyl-O-C1-amido-PEG2-C2-NHS ester		/	Unkown
HY-126515	Propargyl-O-C1-amido-PEG4-C2-NHS ester		/	Unkown
HY-126527	N3-PEG2-C2-PFP ester		/	Unkown
HY-126529	N3-PEG3-C2-PFP ester		/	Unkown
HY-126673	Mal-C2-Gly3-EDA		/	Unkown
HY-126677	Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA		/	Unkown
HY-126949	Aminooxy-PEG3-azide		/	Unkown
HY-128741S2	D-Allose-13C-2		/	Unkown
HY-128753S3	D-Lyxose-13C-2		/	Unkown
HY-128793S	trans-Stilbene-13C2		/	Unkown
HY-129772	Phthalimide-PEG3-C2-OTs		/	Unkown
HY-130090	NHPI-PEG4-C2-Pfp ester		/	Unkown
HY-130092	NHPI-PEG3-C2-Pfp ester		/	Unkown
HY-130093	NHPI-PEG3-C2-NHS ester		/	Unkown
HY-130094	NHPI-PEG2-C2-Pfp ester		/	Unkown
HY-130096	Ald-Ph-amido-C2-nitrate		/	Unkown
HY-130102	Ald-Ph-amido-PEG3-C2-Pfp ester		/	Unkown
HY-130103	Ald-Ph-amido-PEG2-C2-Pfp ester		/	Unkown
HY-130105	Ald-Ph-amido-PEG1-C2-Pfp ester		/	Unkown
HY-130106	Ald-Ph-amido-PEG1-C2-NHS ester		/	Unkown
HY-130154	Ald-Ph-amido-PEG2-C2-acid		/	Unkown
HY-130164	Bromo-PEG3-C2-phosphonic acid		/	Unkown
HY-130174	Ald-Ph-amido-PEG3-C2-NH2		/	Unkown
HY-130192	Cbz-NH-PEG8-C2-acid		/	Unkown
HY-130202	Ald-Ph-amido-PEG2-C2-Boc		≥97.0%	Unkown
HY-130443	Cbz-NH-PEG6-C2-acid		/	Unkown
HY-130467	DNP-NH-PEG2-C2-acid		/	Unkown
HY-130488	Hydroxy-PEG2-C2-PFP ester		/	Unkown
HY-130489	Bromo-PEG5-C2-acid		/	Unkown
HY-130491	DNP-NH-PEG4-C2-Boc		/	Unkown
HY-130654	(S,R,S)-AHPC-C2-PEG4-N3		/	Unkown
HY-130667	Ald-Ph-amido-C2-PEG3-azide		98.92%	Unkown
HY-130669	Ald-Ph-amido-C2-PEG3-NH-Boc		/	Unkown
HY-130690	Propargyl-PEG1-SS-PEG1-C2-Boc		≥98.0%	Unkown
HY-130712	NH2-C2-amido-C2-Boc		/	Unkown
HY-130713	Thalidomide-C2-amido-C2-COOH	Inducer	/	Unkown
HY-130758	Ald-PEG1-C2-Boc		/	Unkown
HY-130931	Propargyl-NH-PEG3-C2-NHS ester		/	Unkown
HY-131992	N-Acetylpsychosine		/	Unkown
HY-132973	MC-Val-Cit-PAB-NH-C2-NH-Boc		≥95.0%	Unkown
HY-133069	Tos-PEG2-C2-Boc		/	Unkown
HY-133071	Tos-PEG6-C2-Boc		/	Unkown
HY-133410	Mal-C2-cyclohexylcarboxyl-hydrazide TFA		/	Unkown
HY-133410A	Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride		98.23%	Unkown
HY-133509	DBCO-C2-SulfoNHS ester		/	Unkown
HY-133546	Ald-Ph-amido-PEG11-C2-NH2		/	Unkown
HY-133583	Propargyl-O-C1-amido-PEG3-C2-NHS ester		/	Unkown
HY-13407S	Gossypol-13C2		/	Unkown
HY-13417S	AICAR-13C2,15N		/	Unkown
HY-13458S1	Droxidopa-13C2,15N hydrochloride		/	Unkown
HY-135931	m-PEG11-C2-NHS Ester		/	Unkown
HY-135959	DBCO-NH-PEG7-C2-NHS ester		/	Unkown
HY-136162A	Thalidomide-4-O-C2-NH2	Inducer	/	Unkown
HY-136163A	(S,R,S)-AHPC-C2-NH2		/	Unkown
HY-13623CS	(1R,3S,4R)-ent-Entecavir-13C2,15N		/	Unkown
HY-13623S1	Entecavir-13C2,15N		/	Unkown
HY-138083	Parvodicin C2	Inhibitor	/	Unkown
HY-138316	THP-PEG10-C2-Boc		/	Unkown
HY-138349	THP-PEG6-C2-Boc		/	Unkown
HY-138358	Azido-PEG23-C2-azide		/	Unkown
HY-138362	Br-PEG6-C2-acid		/	Unkown
HY-138370	Boc-NH-PEG4-C2-Boc		/	Unkown
HY-138375	Mal-PEG5-C2-NH2 hydrochloride		/	Unkown
HY-138380	Mal-PEG4-C2-NH2 TFA		/	Unkown
HY-138381	Br-PEG6-C2-NHBoc		/	Unkown
HY-138384	Br-PEG9-C2-NHBoc		/	Unkown
HY-138390	NH2-PEG10-C2-dimethylamino		/	Unkown
HY-138397	Boc-NH-PEG15-C2-acid		/	Unkown
HY-138399	Boc-NH-PEG22-C2-NH2		/	Unkown
HY-138406	Boc-NH-PEG8-C2-Br		/	Unkown
HY-138410	Boc-NH-PEG11-C2-acid		/	Unkown
HY-138425	Amino-PEG12-C2-azide		/	Unkown
HY-138432	Boc-NH-PEG26-C2-NH2		/	Unkown
HY-138464	Br-Boc-C2-azido		/	Unkown
HY-138474	Boc-PEG1-PPG2-C2-azido		/	Unkown
HY-138485	Boc-PEG1-PPG2-C2-NH2		/	Unkown
HY-138535	Azide-C2-Azide		/	Unkown
HY-138849	Thalidomide-NH-amido-C2-NH2	Inducer	/	Unkown
HY-138849A	Thalidomide-NH-amido-C2-NH2 hydrochloride	Inducer	/	Unkown
HY-138854	Thalidomide-NH-amido-PEG1-C2-NH2	Inducer	/	Unkown
HY-138854A	Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride	Inducer	/	Unkown
HY-138855	Thalidomide-NH-amido-PEG2-C2-NH2	Inducer	/	Unkown
HY-138855A	Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride	Inducer	/	Unkown
HY-138856	Thalidomide-NH-amido-PEG3-C2-NH2	Inducer	/	Unkown
HY-138856A	Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride		/	Unkown
HY-138857	Thalidomide-NH-amido-PEG4-C2-NH2		/	Unkown
HY-138857A	Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride		/	Unkown
HY-138965A	Pomalidomide-5-C2-NH2 hydrochloride		/	Unkown
HY-139084	XL388-C2-NH2		/	Unkown
HY-139085A	XL388-C2-amide-PEG9-NH2 hydrochloride		≥95.0%	Unkown
HY-139085B	XL388-C2-amide-PEG9-NH2 TFA		95.97%	Unkown
HY-140001	Amino-PEG3-C2-sulfonic acid		/	Unkown
HY-140011	Acid-C2-PEG3-NHS ester		/	Unkown
HY-140067	endo-BCN-PEG2-C2-NHS ester		/	Unkown
HY-140085	N-(PEG2-C2-acid)-N-bis(PEG2-propargyl)		/	Unkown
HY-140101	Azido-C2-SS-PEG2-C2-acid		/	Unkown
HY-140164	Azido-PEG2-C2-sulfonic acid		/	Unkown
HY-140221	Azido-PEG1-C2-methylamine		/	Unkown
HY-140287	DBCO-C2-PEG4-amine		/	Unkown
HY-140294	DBCO-C2-PEG4-NH-Boc		/	Unkown
HY-140349	AZD-CO-C2-Ph-amido-Ph-azide		/	Unkown
HY-140406	Aminooxy-PEG3-C2-NH-Boc		/	Unkown
HY-140487	Cbz-NH-PEG2-C2-acid		/	Unkown
HY-140489	Cbz-NH-PEG5-C2-acid		/	Unkown
HY-140514	NH-bis(PEG2-C2-acid)		/	Unkown
HY-140550	NH-bis(C2-PEG1-azide)		/	Unkown
HY-140554	N-Boc-N-bis(C2-PEG1-azide)		/	Unkown
HY-140595	m-PEG3-S-PEG1-C2-Boc		/	Unkown
HY-140633	Ald-C2-PEG4-azide		/	Unkown
HY-140750	Benzyloxy carbonyl-PEG3-C2-Boc		/	Unkown
HY-140776	Azido-PEG2-C2-Boc		/	Unkown
HY-140834	Boc-N-Amido-PEG2-C2-azide		/	Unkown
HY-141116	Boc-N-PEG1-C2-NHS ester		/	Unkown
HY-141122	Boc-PEG4-C2-NHS ester		/	Unkown
HY-141245	Hydroxy-PEG4-C2-nitrile		/	Unkown
HY-141323	C2-Bis-phosphoramidic acid diethyl ester		/	Unkown
HY-141388	Bromoacetamido-PEG3-C2-Boc		/	Unkown
HY-141663	2',3'-cGAMP-C2-SH		/	Unkown
HY-141798	OICR-9429-N-C2-NH2		/	Unkown
HY-141878	di-Ellipticine-RIBOTAC	Modulator	/	Unkown
HY-143784S	C14 Benzalkonium-1 acid-13C2,d11 chloride		/	Unkown
HY-143943S	Felodipine 3,5-dimethyl ester-13C2,d6		/	Unkown
HY-144128	hGGPPS-IN-1		/	Unkown
HY-144129	hGGPPS-IN-2		/	Unkown
HY-144130	hGGPPS-IN-3		/	Unkown
HY-144150S	Pelubiprofen impurity 2-13C2,d6		/	Unkown
HY-144153S	S-(1,2-Dichlorovinyl)glutathione-13C2,15N		/	Unkown
HY-144427S	Vitamin E-13C2,d6		/	Unkown
HY-145247	Biotin-PEG7-C2-S-Vidarabine	Inhibitor	/	Unkown
HY-145248	Biotin-PEG7-C2-NH-Vidarabine-S-CH3	Inhibitor	/	Unkown
HY-145253	Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	Unkown
HY-145255	Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH	Inhibitor	/	Unkown
HY-14608S10	L-Glutamic acid-13C2		/	Unkown
HY-146194	NHEJ inhibitor-1	Activator	/	Unkown
HY-146196	Anticandidal agent-1	Inhibitor	/	Unkown
HY-146573	AKR1C3-IN-6	Inhibitor	/	Unkown
HY-146994S2	L-Idose-13C-2		/	Unkown
HY-147716	CDK8-IN-6	Inhibitor	/	Unkown
HY-147717	CDK8-IN-7	Inhibitor	/	Unkown
HY-147835	Antibacterial agent 109	Inhibitor	/	Unkown
HY-148171	L-2'-Fd4C	Inhibitor	/	Unkown
HY-148472A	C2-Amide-C4-NH2		/	Unkown
HY-148662	Pomalidomide-PEG5-C2-NH2 hydrochloride		/	Unkown
HY-149255	PTP1B/AKR1B1-IN-2	Inhibitor	/	Unkown
HY-150525S	Acetyl-1,2 Coenzyme A-13c2 Lithium		/	Unkown
HY-150623	SARS-CoV-2 nsp13-IN-2	Inhibitor	/	Unkown
HY-150631S	Glutathione-glycine-13C2,15N trifluoroacetate		/	Unkown
HY-150915S	Uracil 4,5-13c2		/	Unkown
HY-152297	(1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol		/	Unkown
HY-152305	(1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol		/	Unkown
HY-152463	4′-C-2-Propen-1-yluridine		/	Unkown
HY-153042	Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride		/	Unkown
HY-153371	50-C2-C9-4tail		/	Unkown
HY-153538	AP-C2	Inhibitor	/	Unkown
HY-15388S1	Tazarotene-13C2,d2		/	Unkown
HY-155705	BMP agonist 1		/	Unkown
HY-156304	Coumarin-C2-TCO		/	Unkown
HY-156305	Coumarin-C2-exo-BCN		/	Unkown
HY-156882	Biotin-PEG3-amide-C2-CO-Halofuginone		/	Unkown
HY-157386S	8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2		/	Unkown
HY-157588	(S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH	Inducer	/	Unkown
HY-157749	Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3	Inducer	/	Unkown
HY-157758	(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3	Inducer	/	Unkown
HY-157759	(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH	Inducer	/	Unkown
HY-157760	(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH	Inducer	/	Unkown
HY-160449	p53 Activator 10	Activator	/	Unkown
HY-160514	LXQ46	Inhibitor	/	Unkown
HY-161183	(S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc	Inducer	/	Unkown
HY-161184	Deoxy-thalidomide-piperidine-C-piperazine-C2-OH	Inducer	/	Unkown
HY-161186	Thalidomide-piperidine-C-azetidine-C2-O-C-boc	Inducer	/	Unkown
HY-161188	Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH	Inducer	/	Unkown
HY-161189	Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc	Inducer	/	Unkown
HY-161190	Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH	Inducer	/	Unkown
HY-161191	Thalidomide-azetidine-piperazine-C2-O-C2-OH	Inducer	/	Unkown
HY-161197	Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH	Inducer	/	Unkown
HY-161199	Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH	Inducer	/	Unkown
HY-161200	Thalidomide-piperazine-C-azetidine-C2-OH	Inducer	/	Unkown
HY-161202	Thalidomide-piperidine-O-piperidine-C2-OH	Inducer	/	Unkown
HY-161203	Thalidomide-azetidine-piperazine-C2-O-C-boc	Inducer	/	Unkown
HY-161250	Pomalidomide-NH-PEG6-amide-C2-CPI-1612		/	Unkown
HY-161393	RB-CO-PEG5-C2-CO-VH032		/	Unkown
HY-161394	SPRT		/	Unkown
HY-161767	JWJ-01-306		/	Unkown
HY-161839	AKR1C2/3-IN-1	Inhibitor	/	Unkown
HY-161910	SH-E4A-66	Inhibitor	/	Unkown
HY-162046	Anticancer agent 178	Inducer	/	Unkown
HY-162081	BTK-IN-32	Inhibitor	/	Unkown
HY-16271S	Kevetrin hydrochloride-13C2,15N3	p53 Activator	/	Unkown
HY-163078	C2-Gal-Dox		/	Unkown
HY-163224	(S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc		/	Unkown
HY-163228	PROTAC PTK6 ligand-O-C2-O-piperidine-Boc		/	Unkown
HY-163788	C5-CONH-C2-N-CH3		/	Unkown
HY-163903	OH-C2-PEG3-NHCO-C3-COOH		/	Unkown
HY-163904	(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH		/	Unkown
HY-163930	(S,R,S)-AHPC-CO-cyclohexane-C2		/	Unkown
HY-163986	Pomalidomide-C2-NHCO-C6		/	Unkown
HY-164210	DBCO-PEG2-C2-acid		/	Unkown
HY-164212	DBCO-PEG1-OH		/	Unkown
HY-164785	TCO-PEG5-C2-Mal		≥95.0%	Unkown
HY-168016	PROTAC YAP degrader-1		/	Unkown
HY-168019	(R,S,R)-AHPC-PEG2-C2-boc		/	Unkown
HY-169082	JQ-1 (carboxylic acid)-NH-C2-NH-COOH		/	Unkown
HY-169141	BIIB021-NH-C2-piperidine-CO-Me		/	Unkown
HY-169150	JQ-1 carboxylic acid-PEG3-C2-NH2		/	Unkown
HY-169236	COOH-C-PEG2-NHCO-C2-COOH		/	Unkown
HY-169237	Pomalidomide-C2-CONH-PEG2-C-COOH		/	Unkown
HY-17416AS1	Guanfacine-15N3,13C2	Agonist	/	Unkown
HY-17530S	Aldicarb sulfone-13C2,d3		/	Unkown
HY-34628S2	Tri-O-acetyl-D-glucal-13C-2		/	Unkown
HY-40171S	NH2-C2-NH-Boc-d4		/	Unkown
HY-48394A	Bis-S-C2-N(N-Me)-C2-OH dihydrochloride		/	Unkown
HY-77956S2	Thyminose-13C-2		/	Unkown
HY-79369S1	Succinic anhydride-13C2		/	Unkown
HY-90009AS	Tadalafil-13C2,d3		/	Unkown
HY-A0084S1	Procainamide-13C2 hydrochloride		/	Unkown
HY-B0101S1	Fluconazole-13C2,15N	Inhibitor	/	Unkown
HY-B0141S5	Estradiol-13C2	Agonist	/	Unkown
HY-B0149S3	Tranexamic acid-13C2,15N		/	Unkown
HY-B0151S1	Pregnenolone-13C2,d2		/	Unkown
HY-B0216S2	Ethynyl Estradiol-13C2	Agonist	/	Unkown
HY-B0220S3	Erythromycin-13C2	Inhibitor	/	Unkown
HY-B0234S3	Estrone-13C2	Agonist	/	Unkown
HY-B0283S1	Acipimox-13C2,15N2		/	Unkown
HY-B0389S12	D-Glucose-13C-2		/	Unkown
HY-B0389S14	D-Glucose-13C2		/	Unkown
HY-B0389S22	D-Glucose-13C2,d2		/	Unkown
HY-B0400S3	D-Sorbitol-13C-2		/	Unkown
HY-B0495S3	Lamotrigine-13C2,15N		/	Unkown
HY-B0495S6	Lamotrigine-13C2,15N2,d3		/	Unkown
HY-B0508S1	Ornidazole-13C2,15N2	Inhibitor	/	Unkown
HY-B0523S	Anagrelide-13C2,15N,d2		/	Unkown
HY-B0579S3	Cyclosporin A-13C2,d4	Inhibitor	/	Unkown
HY-B0712S1	Ceftriaxone-13C2,d3 triethylammonium salt	Inhibitor	/	Unkown
HY-B0782S1	Acetazolamide-13C2,d3		/	Unkown
HY-B0863S3	Glyphosate-13C2,15N	Inducer	/	Unkown
HY-B1118S1	Secnidazole-13C2, 15N2	Inhibitor	/	Unkown
HY-B1337S5	Choline-13C2 chloride		/	Unkown
HY-B1449S3	Uridine-13C-2		/	Unkown
HY-B1640S	Ethacrynic acid-13C2,d5		/	Unkown
HY-B1659S4	Glycerol-13C2		/	Unkown
HY-B1842S	Fluroxypyr-13C2		/	Unkown
HY-B1912S1	Amidosulfuron-13C2,d6		/	Unkown
HY-D1546	Biotin-C2-maleimide		/	Unkown
HY-D1551	10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide		/	Unkown
HY-I0400S2	N-Acetylneuraminic acid-13C-2		/	Unkown
HY-I0626S	Cytosine-2,4-13C2-1,3-15N2		/	Unkown
HY-I0736S	Isonicotinic acid-d4		/	Unkown
HY-N0059S2	D-arabinose-13C-2		/	Unkown
HY-N0210S1	D-Galactose-13C-2		/	Unkown
HY-N0379S7	D-Mannose-13C-2		/	Unkown
HY-N0390S10	L-Glutamine-1,2-13C2		/	Unkown
HY-N0394S4	L-Cystine-3,3'-13C2		/	Unkown
HY-N0420S3	Butanedioic acid-13C2		≥99.0%	Unkown
HY-N0420S4	Succinic acid-13C2		/	Unkown
HY-N0473S6	L-Tyrosine-3,5-13C2		99.43%	Unkown
HY-N0545S	Taurocholic acid-13C2,15N sodium	Agonist	/	Unkown
HY-N0602R	Ginsenoside Rg2 (Standard)	Inhibitor	/	Unkown
HY-N0666S7	L-Aspartic acid-1,4-13C2,15N		/	Unkown
HY-N10579	Chrexanthomycin C	Modulator	/	Unkown
HY-N10595	Ladanetin-6-O-β-(6′′-O-acetyl)glucoside		/	Unkown
HY-N10642	Pedaliin 6''-acetate		/	Unkown
HY-N10869	Pseudolaric acid C2-O-β-D-glucoside		/	Unkown
HY-N1150S4	Thymidine-13C-2		/	Unkown
HY-N12447	C-2′-Decoumaroylaloeresin G		/	Unkown
HY-N1420AS2	Rhamnose-13C-2 monohydrate		/	Unkown
HY-N1480S2	(-)-Fucose-13C-2		/	Unkown
HY-N3205	Neochamaejasmin B		/	Unkown
HY-N3231	Murraol	Inhibitor	/	Unkown
HY-N3671	Cycloshizukaol A		/	Unkown
HY-N3686S2	D-Arabitol-13C-2		/	Unkown
HY-N3697	Demethoxydeacetoxypseudolaric acid B		99.94%	Unkown
HY-N6625S	Chlorothalonil-13C2	Inhibitor	/	Unkown
HY-N6910	Pseudolaric Acid C2		99.17%	Unkown
HY-N7092S3	D-Fructose-13C2		≥98.0%	Unkown
HY-N7398S	2-Pentylfuran-13C2		/	Unkown
HY-P10655	Caloxin 1C2	Inhibitor	/	Unkown
HY-R00539	hsa-miR-30c-2-3p mimic		/	Unkown
HY-R00539A	hsa-miR-30c-2-3p agomir		/	Unkown
HY-RI00539	hsa-miR-30c-2-3p inhibitor		/	Unkown
HY-RI00539A	hsa-miR-30c-2-3p antagomir		/	Unkown
HY-RS00535	AKR1C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01199	ATP2C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01227	ATP6V1C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01738	C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01740	C2CD3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01741	C2CD5 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01742	C2orf69 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS05907	GTF3C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS05968	H3C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS05975	H4C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09537	NR2C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09538	NR2C2AP Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09547	NR3C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09548	Nr3c2 Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09549	Nr3c2 Rat Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS09609	NT5C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10511	PIK3C2A Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10512	Pik3c2a Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10513	Pik3c2a Rat Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10514	PIK3C2B Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10515	Pik3c2b Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10516	Pik3c2b Rat Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10517	PIK3C2G Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10518	Pik3c2g Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10519	Pik3c2g Rat Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS14017	SULT1C2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W006057AS	Sodium 3-methyl-2-oxobutanoate-13C2,d1		/	Unkown
HY-W006057AS17	Sodium 3-Methyl-2-oxobutanoic acid-13C2		/	Unkown
HY-W006057AS3	Sodium 3-methyl-2-oxobutanoate-13C2,d4		/	Unkown
HY-W008807S	Phosphoenolpyruvic acid potassium-13C2		/	Unkown
HY-W010042S2	L-Glucose-13C-2		/	Unkown
HY-W010452S2	3-Hydroxybutyric acid-13C2 sodium		/	Unkown
HY-W012684S	Ethane-1,2-diamine dihydrochloride-13C2		/	Unkown
HY-W012864S2	(2S,3R)-2,3,4-Trihydroxybutanal-13C-2		99.4%	Unkown
HY-W013061S5	Propane-1,2,3-triyl tripalmitate-13C2		/	Unkown
HY-W013495S	Porphobilinogen-13C2		/	Unkown
HY-W013636S4	2-Ketoglutaric acid-13C2	Inhibitor	/	Unkown
HY-W015410S	Disodium succinate-13C2		/	Unkown
HY-W015883AS	Fumaric acid2,3-13C2 disodium		/	Unkown
HY-W015883S2	Fumaric acid-13C2,d2		/	Unkown
HY-W015913S4	2-Oxopropanoate-13c2 sodium		/	Unkown
HY-W017018S1	L-Ornithine-1,2-13C2 hydrochloride		/	Unkown
HY-W017072S	1-Dodecene-1,2-13C2		/	Unkown
HY-W017522S6	Adipic acid-13C2		/	Unkown
HY-W018772S16	D-Ribose-1,2-13C2		/	Unkown
HY-W018772S3	D-Ribose-13C-2		/	Unkown
HY-W019796	Cbz-NH-PEG4-C2-acid		/	Unkown
HY-W035903S	Ethanolamine-13C2 hydrochloride		/	Unkown
HY-W040028	Cartap hydrochloride	Inducer	/	Unkown
HY-W040240S2	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2		/	Unkown
HY-W042357S3	Ac-rC Phosphoramidite-13C2,d1		/	Unkown
HY-W048482S	rU Phosphoramidite-13C2,d1		/	Unkown
HY-W096111A	Trt-PEG4-C2-acid hydrate		/	Unkown
HY-W096132	Dimethylamino-PEG2-C2-NH2		/	Unkown
HY-W099580S	Hexadecane-1,2-13C2		/	Unkown
HY-W100312S	o-Toluidine-13C6 hydrochloride		/	Unkown
HY-W338294S1	2'-Deoxycytidine-13C-2 monohydrate		/	Unkown
HY-W584529	VH032-C2-NH-Boc		/	Unkown
HY-W584532	VH032-O-C2-NH-Boc		/	Unkown
HY-W588192S	1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4		/	Unkown
HY-W590667	C2 Ceramide-1-phosphate		/	Unkown
HY-W766769	Cyproterone Acetate-13C2,d3	Antagonist	/	Unkown
HY-W778203	Glycolic acid-13C2		/	Unkown
HY-W877850	Mal-C5-N-bis(PEG2-C2-acid)		/	Unkown
HY-Y0219S	1,2,4-Triazole-13C2,15N3		/	Unkown
HY-Y0262BS	Oxalic Acid-13C2 disodium		/	Unkown
HY-Y0338S1	Ethylene glycol-13C2		/	Unkown
HY-Y0383S2	Dimethyl terephthalate-13C2-1		/	Unkown
HY-Y0418S2	Dulcite-13C-2		/	Unkown
HY-Y0677S	Carbethoxymethyldiethyl phosphonate-C13		/	Unkown
HY-Y0781S3	Pyruvic acid-13C-2 sodium		/	Unkown
HY-Y0966S11	Glycine-13C2,15N,d2		/	Unkown
HY-Y0989S2	Acetophenone-1,2-13C2		/	Unkown
HY-Y1088S	Hydrocinnamic acid-2,3-13C2		/	Unkown
HY-Y1250S5	Fmoc-Gly-OH-13C2		/	Unkown
HY-Y1250S6	Fmoc-Gly-OH-13C2,15N	Inhibitor	/	Unkown
HY-100043S	2-Ethyl-3,5-dimethylpyrazine-13C2		/	Unkown
HY-114293S	Acetyl coenzyme A-13C2 lithium	Inhibitor	/	Unkown
HY-116700	Hinnuliquinone	Inhibitor	/	Unkown
HY-118560S	Tricyclodecenyl acetate-13C2		/	Unkown
HY-119799	UK-500001	Inhibitor	/	Unkown
HY-121656	AKR1C2/3-IN-2		/	Unkown
HY-125026	MyomiRs-IN-1		/	Unkown
HY-125571	A 74704	Inhibitor	/	Unkown
HY-126830	Antifolate C2		/	Unkown
HY-129252	Prothracarcin	Inhibitor	/	Unkown
HY-130155	AMPK activator C2	Activator	/	Unkown
HY-132212	LH1307	Inhibitor	/	Unkown
HY-132223	LH1306	Inhibitor	/	Unkown
HY-132644S1	3-Demethyl Thiocolchicine--13C2,d6		/	Unkown
HY-135928	Biotin-C2-S-S-pyridine		/	Unkown
HY-140157	N-Me-N-bis(PEG4-C2-Boc)		/	Unkown
HY-14164S1	Zileuton-13C2,15N	Inhibitor	/	Unkown
HY-144348S	N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N		/	Unkown
HY-149559	Thalidomide-5-O-C2-NH2 hydrochloride		98.01%	Unkown
HY-150006	Pomalidomide-C2-acid		/	Unkown
HY-15121S1	L-Theanine-13C2,15N2		/	Unkown
HY-156326S	(3E,5E)-Octadien-2-one-13C2		/	Unkown
HY-156326S1	(3E,5Z)-Octadien-2-one-13C2		/	Unkown
HY-158343	Thalidomide-NH-PEG2-C2-CH2		/	Unkown
HY-160069	Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH		/	Unkown
HY-160235	Pomalidomide-C2-amide-C5-azide		/	Unkown
HY-161773	HL389-NHC2-PEG3-C2NH		/	Unkown
HY-164043	(S,R,S)-AHPC(Me)-amido-C2-acid		/	Unkown
HY-164391	Pomalidomide-C2-amide-C4-Br		/	Unkown
HY-165064	C2 L-Erythro ceramide (d18:1/2:0)		/	Unkown
HY-165072	C2 3'-Sulfo galactosylceramide (d18:1/2:0)		/	Unkown
HY-166226	C2 Sphingomyelin (d18:1/2:0)		/	Unkown
HY-167710	CRCD2		/	Unkown
HY-76204S1	Glycine ethyl ester-13C2 hydrochloride		/	Unkown
HY-B0084S3	Dienogest-13C2,15N	Agonist	/	Unkown
HY-B0124S1	Zonisamide-13C2,15N		/	Unkown
HY-B1290S3	2-Phenylethanol-13C2	Inhibitor	/	Unkown
HY-N0091S4	Hypoxanthine-13C2,15N-1		/	Unkown
HY-N12156	Ajugasterone C 2-acetate		/	Unkown
HY-N12297	Ciwujianoside C2		/	Unkown
HY-N7125S	Cinnamyl acetate-13C2		/	Unkown
HY-N7521	Procyanidin C2		/	Unkown
HY-N9484S	Menthofuran-13C2		/	Unkown
HY-W001942S2	DL-2-Methylbutyric acid-13C2		/	Unkown
HY-W007596	Tris(2-phenylpyridinato-C2,N)iridium(III)		≥98.0%	Unkown
HY-W010392S1	Ethyl 2-methylbutanoate-13C2		/	Unkown
HY-W010489S1	2-Phenylacetaldehyde-13C2		/	Unkown
HY-W012980S4	Isovaleric acid-13C2		/	Unkown
HY-W012998S1	2,3-Pentanedione-13C2		/	Unkown
HY-W015307S	4-Ethyloctanoic acid-13C2		/	Unkown
HY-W015604S	2,3-Diethyl-5-methylpyrazine-13C2		/	Unkown
HY-W017049S	Trifluoroacetic acid-13C2 sodium		/	Unkown
HY-W020678S	2-Methylbutanal-13C2		/	Unkown
HY-W102356S1	Phenethyl acetate-13C2		/	Unkown
HY-W127515S	trans-2,cis-6-Nonadienal-13C2		/	Unkown
HY-W343292S	2-Methylbutyl acetate-13C2		/	Unkown
HY-W590664	C2 Dihydroceramide		/	Unkown
HY-W654105	C18-Ceramide-13C2,d2		/	Unkown
HY-W654190	Fipronil sulfone-13C2,15N2		/	Unkown
HY-W654241	Isopentenyl pyrophosphate-13C2		/	Unkown
HY-W749251	5-Aminolevulinic acid-13C2,15N hydrochloride		/	Unkown
HY-W777583	2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6		/	Unkown
HY-W778064	L-threo-Droxidopa-13C2,15N		/	Unkown
HY-W778154	O,O-Dimethyl dithiophosphate-13C2 ammonium	Inhibitor	/	Unkown
HY-W779002	alpha-D-glucose-13C2-1		/	Unkown
HY-Y0045S	2-Acetylthiazole-13C2		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Felis catus	C2	VGNC	VGNC:102387
Bos taurus	C2	VGNC	VGNC:53959
Mus musculus	C2	MGD	MGI:88226
Canis familiaris	C2	VGNC	VGNC:103663
Rattus norvegicus	C2	RGD	RGD:2231
Macaca fascicularis	C2	NCBI	NCBI:102137096
Macaca mulatta	C2	NCBI	NCBI:106997899
Others	C2	NCBI

Name
Email *

	Sorry, but the email address you supplied was invalid.